Company Quick10K Filing
OncBioMune
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-25
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-15
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-06-19
10-K 2017-12-31 Filed 2018-05-31
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-09-14
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-13
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-08-31 Filed 2015-10-20
10-Q 2015-05-31 Filed 2015-07-20
10-K 2015-02-28 Filed 2015-05-29
10-Q 2014-11-30 Filed 2015-04-21
10-Q 2014-08-31 Filed 2014-10-14
10-Q 2014-05-31 Filed 2014-07-21
10-K 2014-02-28 Filed 2014-06-13
10-Q 2013-11-30 Filed 2014-01-14
10-Q 2013-08-31 Filed 2013-10-17
10-K 2013-02-28 Filed 2013-06-28
10-Q 2012-11-30 Filed 2013-01-22
10-Q 2012-08-31 Filed 2012-10-15
10-Q 2012-05-31 Filed 2012-07-13
10-K 2012-02-29 Filed 2012-05-18
10-Q 2011-11-30 Filed 2012-01-17
10-Q 2011-08-31 Filed 2011-10-17
10-Q 2011-05-31 Filed 2011-07-08
10-K 2011-02-28 Filed 2011-05-17
10-Q 2010-11-30 Filed 2011-01-13
10-Q 2010-08-31 Filed 2010-10-08
10-Q 2010-05-31 Filed 2010-06-28
10-K 2010-02-28 Filed 2010-05-05
10-Q 2009-11-30 Filed 2010-01-14
8-K 2020-06-05
8-K 2020-05-28
8-K 2020-05-11
8-K 2020-05-06
8-K 2019-09-09
8-K 2019-06-26
8-K 2019-06-03
8-K 2019-04-29
8-K 2019-03-19
8-K 2018-12-26
8-K 2018-09-24
8-K 2018-07-25
8-K 2018-05-16
8-K 2018-05-15
8-K 2018-03-13
8-K 2018-01-29
8-K 2018-01-29
8-K 2018-01-22

OncBioMune Financials

OBMP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
HyperSolar (HYSR) 0 1.4 131% 0 7 0 0 0 1 2
ProGreen (PGUS) 0 0% -0.1 -176% 2 6 0 0 -3 -0 0
Intercloud Systems (ICLD) 0 21% -1.3 -92% 10 41 10 2 -9 -8 10
Vilacto Bio (VIBI) 0 17% -0.0 -3,636% 1 4 0 0 -20 -20 0
Rennova Health (RNVA) 0 8% -1.3 -236% 17 76 13 1 -39 -22 29
Yinghong Guangda Technology (UBLI) 0 24% 0.0 0 0 1 0 -1 -1 -0
Jiayin Group (JFIN)
Ozop Surgical (OZSC) 0 90% -0.7 -71% 6 10 0 0 -4 -3 2
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 0 2 0 0 -4 -4 0
Cerebain Biotech (CBBT) 0 -2.4 -7,969% 0 7 0 0 -2 -1 3
OncBioMune (OBMP) 0 0.0 -1,707% 0 14 0 0 -7 -6 -0
Triton Emission Solutions (DSOX) 0 0.0 -10,306% 0 19 0 0 -2 -1 -0
Daniels Corporate Advisory (DCAC) 0 22% -0.4 50% 1 3 2 1 0 0 -0
Kibush Capital (DLCR) 0 33% -0.2 -213% 0 3 0 0 -0 -0 0
Bingo Nation (BLTO)
PropTech Acquisition Corp (PTACU)
True Drinks Holdings (TRUU) 0 57% 1.7 -26% 10 8 12 7 -3 -2 -4
Data Call Technologies (DCLT) 0 70% 0.7 -21% 0 0 0 0 -0 -0 -0
9F (JFU)
Ironclad Encryption (IRNC) 0 0.0 -1,440% 1 5 0 0 -8 -7 -0

Balance Sheet ($MM)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash0000001000000000001000000000000000
Accounts Receivable00000000000
Inventory0000000000
PP&E0000000000000000
Assets1111211001000000001000055000000000
Accounts Payable000011100001111
Long-Term Debt
Liabilities1111111111111110000000133415510118121314
Stockholders' Equity0000110-0-0-0-1-1-1-1-1-0-0-010-0-0-122-4-15-5-10-10-8-11-13-14
Income Statement ($MM)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000-0-0000000000000000000-0000000
Cost of Revenue00000000000
Gross Profit00000-0-0-0000
R&D0000000000000000
SG&A00000000000000-000000000000-0000000
Tax000000000000000000
Net Income-0-00-01-0-1-00-0-0-00-00-0-1-0-1-0-1-0-1-3-0-6-11911-1-4-2-1
Cash Flow ($MM)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-00-0-0-0-0-0-00-0-0-0-0-0-0-0-0-0-0-0-0-1-1-1-0-0-0-1-0-0-0
Cash Investing000001-0-0-000000-000-00-0000
Cash Financing000000-0000000000100001110001000